Prudential Financial Inc. Acquires Shares of 105,945 Aveanna Healthcare Holdings Inc. $AVAH

Prudential Financial Inc. acquired a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 105,945 shares of the company’s stock, valued at approximately $554,000.

Other hedge funds also recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Aveanna Healthcare by 71.1% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 326,144 shares of the company’s stock valued at $1,768,000 after purchasing an additional 135,574 shares during the period. Nuveen LLC acquired a new position in Aveanna Healthcare in the 1st quarter valued at about $1,692,000. Russell Investments Group Ltd. grew its stake in shares of Aveanna Healthcare by 648.7% in the 1st quarter. Russell Investments Group Ltd. now owns 60,921 shares of the company’s stock valued at $330,000 after buying an additional 52,784 shares during the period. Algert Global LLC grew its stake in shares of Aveanna Healthcare by 180.2% in the 1st quarter. Algert Global LLC now owns 120,745 shares of the company’s stock valued at $654,000 after buying an additional 77,650 shares during the period. Finally, Jump Financial LLC acquired a new stake in shares of Aveanna Healthcare during the 1st quarter worth approximately $59,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Paul R. Vigano sold 1,500,000 shares of Aveanna Healthcare stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the sale, the insider owned 362,746 shares of the company’s stock, valued at $3,264,714. The trade was a 80.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares in the company, valued at $3,264,714. The trade was a 80.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 32,597,968 shares of company stock worth $293,381,712. Company insiders own 7.00% of the company’s stock.

Wall Street Analyst Weigh In

AVAH has been the subject of several recent analyst reports. Jefferies Financial Group raised their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price objective for the company. UBS Group boosted their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a report on Friday, November 7th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Finally, JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $10.69.

Check Out Our Latest Analysis on Aveanna Healthcare

Aveanna Healthcare Stock Down 0.8%

Aveanna Healthcare stock opened at $9.13 on Wednesday. The stock has a market cap of $1.91 billion, a PE ratio of 25.36 and a beta of 2.04. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The stock’s fifty day moving average is $9.11 and its two-hundred day moving average is $7.09. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.67 and a 1-year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAHGet Free Report) last issued its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, sell-side analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Aveanna Healthcare Company Profile

(Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Further Reading

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHFree Report).

Institutional Ownership by Quarter for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.